Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cochlear Implants | 1 | 2022 | 58 | 0.820 |
Why?
|
| Cochlear Implantation | 1 | 2022 | 70 | 0.810 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2022 | 82 | 0.800 |
Why?
|
| Speech Perception | 1 | 2022 | 90 | 0.800 |
Why?
|
| Head and Neck Neoplasms | 4 | 2023 | 335 | 0.640 |
Why?
|
| Free Tissue Flaps | 3 | 2023 | 56 | 0.610 |
Why?
|
| Retrospective Studies | 18 | 2023 | 6432 | 0.460 |
Why?
|
| Thyroid Neoplasms | 2 | 2022 | 162 | 0.440 |
Why?
|
| Neck Dissection | 2 | 2021 | 43 | 0.390 |
Why?
|
| Sinusitis | 2 | 2022 | 60 | 0.380 |
Why?
|
| Parathyroidectomy | 2 | 2021 | 75 | 0.370 |
Why?
|
| Stapes Surgery | 2 | 2020 | 21 | 0.360 |
Why?
|
| Tympanoplasty | 2 | 2020 | 57 | 0.340 |
Why?
|
| Meniere Disease | 1 | 2008 | 17 | 0.330 |
Why?
|
| Treatment Outcome | 8 | 2022 | 5604 | 0.330 |
Why?
|
| Otolaryngology | 1 | 2008 | 58 | 0.310 |
Why?
|
| Incidental Findings | 1 | 2007 | 42 | 0.310 |
Why?
|
| Carcinoma | 1 | 2007 | 153 | 0.280 |
Why?
|
| Thyroidectomy | 3 | 2021 | 103 | 0.270 |
Why?
|
| Mandibular Reconstruction | 1 | 2023 | 10 | 0.230 |
Why?
|
| Scapula | 1 | 2023 | 19 | 0.230 |
Why?
|
| Humans | 24 | 2023 | 54284 | 0.230 |
Why?
|
| Tramadol | 1 | 2022 | 29 | 0.220 |
Why?
|
| Reoperation | 2 | 2021 | 454 | 0.220 |
Why?
|
| Surgical Flaps | 1 | 2023 | 135 | 0.210 |
Why?
|
| Parathyroid Hormone | 2 | 2021 | 196 | 0.210 |
Why?
|
| Hearing Loss, Conductive | 2 | 2019 | 52 | 0.210 |
Why?
|
| Recurrent Laryngeal Nerve Injuries | 1 | 2021 | 11 | 0.200 |
Why?
|
| Intraoperative Care | 1 | 2021 | 57 | 0.200 |
Why?
|
| Chylothorax | 1 | 2021 | 16 | 0.200 |
Why?
|
| Hypotension | 1 | 2021 | 67 | 0.190 |
Why?
|
| Vasoconstrictor Agents | 1 | 2021 | 88 | 0.190 |
Why?
|
| Robotics | 1 | 2021 | 45 | 0.190 |
Why?
|
| Paranasal Sinuses | 1 | 2020 | 25 | 0.190 |
Why?
|
| Otosclerosis | 1 | 2020 | 9 | 0.190 |
Why?
|
| Tympanic Membrane Perforation | 1 | 2020 | 19 | 0.190 |
Why?
|
| Morbidity | 1 | 2021 | 149 | 0.190 |
Why?
|
| Rhinitis | 1 | 2020 | 33 | 0.190 |
Why?
|
| Ossicular Prosthesis | 1 | 2020 | 18 | 0.190 |
Why?
|
| Intraoperative Complications | 1 | 2021 | 125 | 0.190 |
Why?
|
| Chlorides | 1 | 2020 | 58 | 0.190 |
Why?
|
| Hyperparathyroidism, Primary | 1 | 2020 | 50 | 0.180 |
Why?
|
| Male | 12 | 2023 | 27334 | 0.180 |
Why?
|
| Postoperative Complications | 3 | 2022 | 1033 | 0.180 |
Why?
|
| Adenoma | 1 | 2021 | 142 | 0.180 |
Why?
|
| Acetaminophen | 1 | 2022 | 349 | 0.170 |
Why?
|
| Adult | 7 | 2022 | 14207 | 0.170 |
Why?
|
| Malleus | 1 | 2019 | 11 | 0.170 |
Why?
|
| Middle Aged | 9 | 2023 | 13088 | 0.160 |
Why?
|
| Diabetes Mellitus | 1 | 2022 | 309 | 0.160 |
Why?
|
| Calcium | 1 | 2020 | 432 | 0.160 |
Why?
|
| Heart Defects, Congenital | 1 | 2023 | 608 | 0.150 |
Why?
|
| Female | 11 | 2023 | 28441 | 0.130 |
Why?
|
| Internship and Residency | 1 | 2020 | 501 | 0.120 |
Why?
|
| Aged | 6 | 2021 | 10054 | 0.120 |
Why?
|
| Radiopharmaceuticals | 2 | 2021 | 238 | 0.110 |
Why?
|
| Breast Neoplasms | 1 | 2022 | 1248 | 0.110 |
Why?
|
| Audiometry | 2 | 2020 | 34 | 0.090 |
Why?
|
| Tympanic Membrane | 2 | 2020 | 39 | 0.090 |
Why?
|
| Postoperative Period | 2 | 2020 | 189 | 0.090 |
Why?
|
| Aged, 80 and over | 3 | 2022 | 3431 | 0.080 |
Why?
|
| Adenoma, Oxyphilic | 1 | 2007 | 17 | 0.080 |
Why?
|
| Whole Body Imaging | 1 | 2007 | 25 | 0.080 |
Why?
|
| Equipment Design | 1 | 2008 | 318 | 0.080 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2007 | 205 | 0.070 |
Why?
|
| Positron-Emission Tomography | 1 | 2007 | 322 | 0.070 |
Why?
|
| Incidence | 1 | 2007 | 1082 | 0.060 |
Why?
|
| Adolescent | 3 | 2020 | 6897 | 0.060 |
Why?
|
| Forearm | 1 | 2023 | 41 | 0.060 |
Why?
|
| Child | 3 | 2020 | 7341 | 0.060 |
Why?
|
| Ibuprofen | 1 | 2022 | 28 | 0.060 |
Why?
|
| Ambulatory Care Facilities | 1 | 2023 | 136 | 0.060 |
Why?
|
| Albumins | 1 | 2022 | 38 | 0.050 |
Why?
|
| Thyroid Gland | 1 | 2022 | 93 | 0.050 |
Why?
|
| Adenoviridae | 1 | 2002 | 58 | 0.050 |
Why?
|
| Pain, Postoperative | 1 | 2022 | 161 | 0.050 |
Why?
|
| Ambulatory Care | 1 | 2023 | 230 | 0.050 |
Why?
|
| Recurrent Laryngeal Nerve | 1 | 2021 | 20 | 0.050 |
Why?
|
| Laryngeal Nerves | 1 | 2021 | 19 | 0.050 |
Why?
|
| Glossectomy | 1 | 2021 | 6 | 0.050 |
Why?
|
| Technetium Tc 99m Sestamibi | 1 | 2021 | 29 | 0.050 |
Why?
|
| Head | 1 | 2021 | 77 | 0.050 |
Why?
|
| Infusions, Intravenous | 1 | 2021 | 231 | 0.050 |
Why?
|
| Radionuclide Imaging | 1 | 2021 | 130 | 0.050 |
Why?
|
| Tongue | 1 | 2021 | 41 | 0.050 |
Why?
|
| Acute Disease | 1 | 2022 | 403 | 0.050 |
Why?
|
| Child, Preschool | 2 | 2020 | 4147 | 0.050 |
Why?
|
| Risk | 1 | 2022 | 343 | 0.050 |
Why?
|
| Neck | 1 | 2021 | 116 | 0.050 |
Why?
|
| Drug Administration Schedule | 1 | 2021 | 401 | 0.050 |
Why?
|
| Arteries | 1 | 2021 | 101 | 0.050 |
Why?
|
| Stapes | 1 | 2020 | 13 | 0.050 |
Why?
|
| Cartilage | 1 | 2020 | 47 | 0.050 |
Why?
|
| Data Collection | 1 | 2022 | 321 | 0.050 |
Why?
|
| Membrane Glycoproteins | 1 | 2002 | 269 | 0.050 |
Why?
|
| Self-Assessment | 1 | 2020 | 50 | 0.050 |
Why?
|
| Doxorubicin | 1 | 2002 | 259 | 0.050 |
Why?
|
| Pilot Projects | 1 | 2022 | 808 | 0.050 |
Why?
|
| Endoscopy | 1 | 2020 | 131 | 0.050 |
Why?
|
| Odds Ratio | 1 | 2021 | 604 | 0.050 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2002 | 434 | 0.040 |
Why?
|
| Young Adult | 2 | 2020 | 4318 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2023 | 1304 | 0.040 |
Why?
|
| Blood Glucose | 1 | 2022 | 489 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2022 | 1228 | 0.040 |
Why?
|
| Prostatic Neoplasms | 1 | 2002 | 415 | 0.040 |
Why?
|
| Follow-Up Studies | 1 | 2023 | 2387 | 0.040 |
Why?
|
| Chronic Disease | 1 | 2020 | 614 | 0.040 |
Why?
|
| Analgesics, Opioid | 1 | 2022 | 501 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2023 | 1213 | 0.040 |
Why?
|
| Risk Assessment | 1 | 2022 | 1361 | 0.040 |
Why?
|
| Clinical Competence | 1 | 2020 | 446 | 0.040 |
Why?
|
| Prospective Studies | 1 | 2022 | 2604 | 0.040 |
Why?
|
| Apoptosis | 1 | 2002 | 1300 | 0.030 |
Why?
|
| Quality of Life | 1 | 2020 | 922 | 0.030 |
Why?
|
| Prognosis | 1 | 2019 | 2118 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2002 | 1300 | 0.030 |
Why?
|
| Cytochrome c Group | 1 | 2002 | 9 | 0.010 |
Why?
|
| BH3 Interacting Domain Death Agonist Protein | 1 | 2002 | 15 | 0.010 |
Why?
|
| TNF-Related Apoptosis-Inducing Ligand | 1 | 2002 | 21 | 0.010 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2002 | 43 | 0.010 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2002 | 96 | 0.010 |
Why?
|
| Genetic Vectors | 1 | 2002 | 139 | 0.010 |
Why?
|
| Ligands | 1 | 2002 | 230 | 0.010 |
Why?
|
| Caspases | 1 | 2002 | 146 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2002 | 477 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2002 | 683 | 0.010 |
Why?
|
| Carrier Proteins | 1 | 2002 | 359 | 0.010 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2002 | 309 | 0.010 |
Why?
|
| Cell Survival | 1 | 2002 | 657 | 0.010 |
Why?
|